|
Predictors of long-term survival in newly diagnosed multiple myeloma (NDMM) patients (pts) enrolled in the Connect MM registry. |
|
|
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Millennium; Onyx |
Consulting or Advisory Role - Celgene; Millennium; Onyx |
Speakers' Bureau - Celgene; Millennium |
Research Funding - Celgene |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Janssen; Millennium; Onyx |
Other Relationship - Celgene |
|
|
Stock and Other Ownership Interests - McKesson |
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Celgene; EMD Serono; Sandoz; Takeda |
|
|
Speakers' Bureau - Celgene; Janssen Oncology; Millennium; Pharmacyclics |
|
|
Consulting or Advisory Role - Celgene |
|
|
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda |
|
|
|
Consulting or Advisory Role - Celgene |
Research Funding - Celgene |
Travel, Accommodations, Expenses - Celgene |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - EveryFit; Gilead Sciences; Janssen |
|
|
|
Consulting or Advisory Role - Celgene; Janssen |
Speakers' Bureau - Celgene; Janssen |
|
|
Consulting or Advisory Role - Amgen; Celgene; Novartis; Takeda |
Research Funding - Pharmacyclics (Inst) |
Travel, Accommodations, Expenses - Amgen; Novartis; Takeda |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Celgene |
|
|
|
Stock and Other Ownership Interests - Celgene |
Patents, Royalties, Other Intellectual Property - Patent on a Graphic tool with applications including the characterization of the use of oncology therapies over time. US patent 7,495,673 B1.; Patent pending on a heat map prediction matrix tool in Multiple Myeloma predicting survival. (Inst) |
|
|
|
Stock and Other Ownership Interests - Celgene |
|
|
|
|
|
Research Funding - Celgene; Takeda |